• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肥胖糖尿病(NOD)小鼠中的自身免疫性糖尿病与对异种移植耐受的抗性

Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice.

作者信息

Gordon Ethel J, Wicker Linda S, Peterson Laurence B, Serreze David V, Markees Thomas G, Shultz Leonard D, Rossini Aldo A, Greiner Dale L, Mordes John P

机构信息

University of Massachusetts Medical School, Diabetes Division, Department of Medicine, 373 Plantation St., Biotech 2, Suite 218, Worcester, MA 01605, USA.

出版信息

Diabetes. 2005 Jan;54(1):107-15. doi: 10.2337/diabetes.54.1.107.

DOI:10.2337/diabetes.54.1.107
PMID:15616017
Abstract

Costimulation blockade induces prolonged rat islet and skin xenograft survival in C57BL/6 mice. Nonobese diabetic (NOD) mice, which are used to model human autoimmune diabetes, are resistant to costimulation blockade-induced allograft tolerance. We tested the hypothesis that NOD mice would also be resistant to costimulation blockade-induced rat xenograft tolerance. We report that rat islet xenograft survival is short in spontaneously diabetic NOD mice treated with a tolerizing regimen of donor-specific transfusion and anti-CD154 antibody. Rat islet xenograft survival is only marginally longer in chemically diabetic NOD mice treated with costimulation blockade but is prolonged further in NOD Idd congenic mice bearing C57-derived chromosome 3 loci. Reciprocally, the presence of NOD-derived chromosome 3 loci shortens islet xenograft survival in tolerized C57BL/6 mice. Islet xenograft survival is longer in tolerized NOD.CD4a(-/-) and (NOD x C57BL/6)F1 mice than in NOD mice but still much shorter than in C57BL/6 mice. Skin xenograft survival in (NOD x C57BL/6)F1 mice treated with costimulation blockade is short, suggesting a strong genetic resistance to skin xenograft tolerance induction. We conclude that the resistance of NOD mice to xenograft tolerance induction involves some mechanisms that also participate in the expression of autoimmunity and other mechanisms that are distinct.

摘要

共刺激阻断可延长C57BL/6小鼠体内大鼠胰岛和皮肤异种移植物的存活时间。非肥胖糖尿病(NOD)小鼠常用于模拟人类自身免疫性糖尿病,对共刺激阻断诱导的同种异体移植耐受具有抗性。我们检验了NOD小鼠对共刺激阻断诱导的大鼠异种移植耐受也具有抗性这一假说。我们报告,在用供体特异性输血和抗CD154抗体的耐受方案治疗的自发性糖尿病NOD小鼠中,大鼠胰岛异种移植物的存活时间较短。在用共刺激阻断治疗的化学性糖尿病NOD小鼠中,大鼠胰岛异种移植物的存活时间仅略长,但在携带C57来源的3号染色体位点的NOD Idd同源基因小鼠中进一步延长。相反,NOD来源的3号染色体位点的存在会缩短耐受的C57BL/6小鼠中胰岛异种移植物的存活时间。在耐受的NOD.CD4a(-/-)和(NOD×C57BL/6)F1小鼠中,胰岛异种移植物的存活时间比NOD小鼠长,但仍比C57BL/6小鼠短得多。在用共刺激阻断治疗的(NOD×C57BL/6)F1小鼠中,皮肤异种移植物的存活时间较短,表明对皮肤异种移植耐受诱导具有很强的遗传抗性。我们得出结论,NOD小鼠对异种移植耐受诱导的抗性涉及一些也参与自身免疫表达的机制以及其他一些不同的机制。

相似文献

1
Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice.非肥胖糖尿病(NOD)小鼠中的自身免疫性糖尿病与对异种移植耐受的抗性
Diabetes. 2005 Jan;54(1):107-15. doi: 10.2337/diabetes.54.1.107.
2
Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.自身免疫性糖尿病(Idd)基因座协同作用,可延长通过共刺激阻断诱导的非肥胖糖尿病(NOD)小鼠胰岛同种异体移植的存活时间。
Diabetes. 2009 Jan;58(1):165-73. doi: 10.2337/db08-0275. Epub 2008 Nov 4.
3
NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction.对自身免疫性糖尿病具有遗传抗性的NOD同源基因小鼠对移植耐受诱导仍具有抗性。
Diabetes. 2003 Feb;52(2):321-6. doi: 10.2337/diabetes.52.2.321.
4
Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3.NOD小鼠中通过共刺激阻断诱导的胰岛移植存活受Idd3等位基因变体的控制。
Diabetes. 2004 Aug;53(8):1972-8. doi: 10.2337/diabetes.53.8.1972.
5
Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.非肥胖糖尿病小鼠中自身免疫与对共刺激阻断诱导的移植耐受的抗性之间的遗传解离。
J Immunol. 2003 Jul 1;171(1):185-95. doi: 10.4049/jimmunol.171.1.185.
6
Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.非肥胖糖尿病小鼠的胰岛移植排斥反应涉及共同γ链以及依赖和不依赖CD28/CD154的机制。
J Immunol. 2003 Oct 1;171(7):3878-85. doi: 10.4049/jimmunol.171.7.3878.
7
NOD mice have a generalized defect in their response to transplantation tolerance induction.非肥胖糖尿病(NOD)小鼠在对移植耐受诱导的反应中存在全身性缺陷。
Diabetes. 1999 May;48(5):967-74. doi: 10.2337/diabetes.48.5.967.
8
Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.自然杀伤T细胞促进大鼠皮肤而非胰岛异种移植物在小鼠体内的植入。
Xenotransplantation. 2009 May-Jun;16(3):135-44. doi: 10.1111/j.1399-3089.2009.00524.x.
9
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.共刺激阻断诱导性共刺激分子和CD40配体,可诱导对胰岛同种异体移植的显性耐受,并预防非肥胖糖尿病(NOD)小鼠的自发性自身免疫性糖尿病。
Diabetes. 2006 Jan;55(1):27-33.
10
Rat islets are not rejected by anti-islet antibodies in mice treated with costimulation blockade.在接受共刺激阻断治疗的小鼠中,大鼠胰岛不会被抗胰岛抗体排斥。
Xenotransplantation. 2014 Jul-Aug;21(4):353-66. doi: 10.1111/xen.12103. Epub 2014 May 8.

引用本文的文献

1
Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.快速清除 T 细胞可使非肥胖型糖尿病小鼠嵌合体稳定,移植后早期即出现高比例的供体细胞与其相关。
Front Immunol. 2018 Apr 24;9:837. doi: 10.3389/fimmu.2018.00837. eCollection 2018.
2
APC-targeted proinsulin expression inactivates insulin-specific memory CD8 T cells in NOD mice.APC 靶向的胰岛素原表达使 NOD 小鼠的胰岛素特异性记忆 CD8 T 细胞失活。
Immunol Cell Biol. 2017 Oct;95(9):765-774. doi: 10.1038/icb.2017.48. Epub 2017 Jun 14.
3
Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.
CD8 T 细胞依赖性记忆的“隐匿”形式破坏移植耐受。
Am J Transplant. 2017 Jul;17(7):1742-1753. doi: 10.1111/ajt.14194. Epub 2017 Feb 21.
4
Mixed chimerism and split tolerance: mechanisms and clinical correlations.混合嵌合与分裂耐受:机制及临床关联
Chimerism. 2011 Oct-Dec;2(4):89-101. doi: 10.4161/chim.2.4.19017.
5
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?1型糖尿病免疫疗法的现状:渐进式进展、巨大飞跃还是原地踏步?
Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18.
6
The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.IL-2/CD25通路决定了人类和非肥胖糖尿病(NOD)小鼠对1型糖尿病的易感性。
J Clin Immunol. 2008 Nov;28(6):685-96. doi: 10.1007/s10875-008-9237-9. Epub 2008 Sep 9.